Scientific Leadership Council

Members of the Scientific Leadership Council (SLC) serve as PHA’s leadership and are cardiologists, pulmonologists and rheumatologists – leading PH experts that branch out into all areas of scientific exploration and treatment of pulmonary hypertension. Not only do they guide the vast array of medical education PHA offers to both the medical and patient communities, they also are involved in the development of cutting edge research exploring various aspects of PH such as the implications of genetics in pulmonary hypertension, treatments for children living with PH, PH and associated diseases and much more.

Many past and present members of the SLC were involved in the creation of the Expert Consensus Document on Pulmonary Hypertension, lead in the development of the Journal Advances in Pulmonary Hypertension and the comprehensive treatment fact sheets and consensus statements available as resources on our website.

The Education Committee provides guidance in the development of patient educational material such as the Patients Survival Guide develops current information on the latest treatments and also develops consensus statements on different aspects of living with pulmonary hypertension.

Mission Statement and Charge

The Education Committee of the Scientific Leadership Counsel was created to support PHA in its mission to advance PH education in the field for both patient and professional populations. In order to grow the educational opportunities, information and resources available to these communities, the Education Committee is charged with the following activities:

  1. The Education Committee will facilitate education through the development of practice consensus statements and treatment fact sheets
  2. The Education Committee will actively work with the PHPN to develop educational materials.
  3. The Education Committee will support the goals of the PHA Medical Education Fund, including projects for the Online University and in-person CME education events.

The Education Committee will convene periodically to discuss progress, evaluate goals and plan.

Ioana Preston, MD (Chair)
Co-Director, Pulmonary Hypertension Center
Associate Professor of Medicine
Tufts University School of Medicine
Boston, Mass.

Sonja Bartolome, MD
Director of Liver Transplant Critical Care
Associate Professor, Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Mardi Gomberg-Maitland, MD
Professor of Medicine, VCU School of Medicine
Director of RV Failure, HFpEF, and Cardio-Oncology Programs
Co-Director of the Pulmonary Vascular Disease Program
Inova Heart and Vascular Institute
3300 Gallows Road
Falls Church, VA 22042

Michael Mathier, MD
Director Pulmonary Hypertension Program and Cardiovascular Fellowship Program
University of Pittsburgh Medical Center
Pittsburgh, Pa.

Namita Sood, MD
Associate Professor, Pulmonary, Allergy, Critical Care & Sleep
Ohio State University, Wexner Medical Center
Columbus, Ohio

Amy Kimber, RN, APNP, PHPN Liaison
Medical College of Wisconsin
Milwaukee, Wis.

Members of the Research Committees are leading researchers in the field of pulmonary hypertension. They guide the growth and development of PHA’s research program with over $15 million in commited funds for pulmonary hypertension research.

Mission Statement and Charge

The Research Committee of the Scientific Leadership Counsel was created to support PHA in its mission to advance PH research in the field for both patient and professional populations. In order to grow the research opportunities, information and resources available to these communities, the Research Committee is charged with supporting the following activities:

  1. The Research Committee will facilitate knowledge of research, including basic and clinical studies, and their findings to patient and professional communities through PHA’s communication channels, including Pathlight, Advances in Pulmonary Hypertension, the PHA Online University, and PHA Classroom.
  2. The Research Committee will actively reach out to relevant agencies to initiate and strengthen relationships so that there will be opportunities for collaboration to enhance research funds and resources sharing.
  3. The Research Committee will advance the goals of the PHA to become a funding body for new research initiatives.
  4. The Research Committee will encourage the development of new PH research and researchers through mentorship by established research leaders in the field who will recruit and lead newer researchers.

The Research Committee will commence periodically to discuss progress, evaluate goals and plan.

Todd Bull, MD, Chair
Associate Professor of Medicine
University of Colorado
Aurora, Colo.
John Newman, MD
Professor of Medicine
Vanderbilt University School of Medicine
Nashville, Tenn.
Karen A. Fagan, MD
Associate Professor of Medicine
Chief of Pulmonolgy, Critical Care
University of South Alabama
Mobile, AL
Vinicio A. de Jesus Perez, MD
Assistant Professor of Medicine
Stanford University
Stanford, Calif.

PHA’s Advances in Pulmonary Hypertension is the most comprehensive journal on pulmonary hypertension. Content is developed by members of the SLC’s Journal Editorial Board.

Members of the Journal Editorial Board develop the quarterly publication Advances in Pulmonary Hypertension, the most comprehensive journal on pulmonary hypertension with a circulation of over 40,000 pulmonologists, cardiologists and rheumatologists in the U.S. and abroad.

Editor-in-Chief

Charles Burger, MD
Professor of Medicine Mayo Clinic College of Medicine
Medical Director, PH Clinic
Mayo Clinic Florida
Jacksonville, Florida

Immediate Past Editor-in-Chief

Myung Park, MD
Chief, Division of Heart Failure and Transplant
Department of Cardiology
Methodist DeBakey Heart & Vascular Center
Houston Methodist Hospital
Houston, Texas

Editor-in-Chief Elect

Harrison Farber, MDProfessor of Medicine Director
Pulmonary Hypertension Center
Boston University/Boston Medical Center
Boston, Massachusetts

Associate Editors

Dunbar Ivy, MD
Professor of Pediatrics
University of Colorado Denver Health Sciences Center
Denver, Colorado

Section Editors

Deborah Jo Levine, MD
Associate Professor
Pulmonary and Critical Care Medicine
Lung Transplant Pulmonologist Director
Pulmonary Hypertension Center Division of Cardiothoracic Surgery
University of Texas Health Science Center
San Antonio San Antonio, Texas

Ioana Preston, MD
Co-Director
Pulmonary Hypertension Center
Tufts Medical Center
Boston, Massachusetts

Sean M. Studer, MD, MSc
Chief of Medicine
Woodhull Medical Center
New York University New York, New York

International Editor 

Fernando Torres, MD
Director, Pulmonary Hypertension Clinic
University of Texas Southwestern Medical Center
Dallas, Texas

Editorial Board

Lynette M. Brown, MD
Assistant Professor of Medicine
University of Utah School of MedicineMurray, Utah

Jeffrey D. Edelman, MD
Associate Professor of Medicine Pulmonary and Critical Care Division
University of Washington
VA Puget Sound Health Care System
Seattle, Washington

Paul Forfia, MD
Associate Professor of Medicine
Medical Director
Pulmonary Hypertension Program and Right Heart Failure Temple Heart and Vascular Center
Temple University School of Medicine
Philadelphia, Pennsylvania

Sean Gaine, MD, PhD
Director, National Pulmonary Hypertension Unit
Mater Misericordiae University Hospital
University College Dublin
Dublin, Ireland

Anna Hemnes, MD
Assistant Professor of Medicine
Assistant Director
Pulmonary Vascular Center Vanderbilt University
Nashville, Tennessee

Richard Krasuski, MD
Professor of Medicine and Pediatrics
Director of the Adult Congenital Heart Disease Center
Director of Hemodynamic Research
Duke University Medical Center
Durham, North Carolina

Usha Krishnan, MD
Associate Professor of Pediatrics
Columbia University Medical Center
Associate Director, Pulmonary Hypertension Center
New York, New York

Jonathan Rich, MD
Assistant Professor in Medicine-Cardiology
Northwestern University Feinberg School of Medicine
Advanced Heart Failure and Transplant Cardiologist
Northwestern Memorial Hospital
Chicago, Illinois

Oksana Shlobin, MD
Co-Director
Pulmonary Hypertension Program
Assistant Director
Advanced Lung Disease and Transplant Program
Inova Health System
Falls Church, Virginia

PHPN Section Editor

Crystal Weber, RN
Nurse Clinician
Duke University Medical Center
Durham, North Carolina

The Scientific Leadership Council (SLC) Insurance Advocacy Committee supports PHA in its mission to educate the pulmonary hypertension (PH) community about insurance while increasing payer awareness about PH treatment and diagnosis best practices.

Mission Statement and Charge

The Insurance Advocacy Committee supports PHA in its mission to educate the pulmonary hypertension (PH) community about insurance while increasing payer awareness about PH treatment and diagnosis best practices. In order to assure that both public and private payers create and adhere to medically-sound policies in the best interest of PH patients, the Insurance Advocacy Committee is charged with supporting the following activities: 

  1. The Insurance Advocacy Committee will guide PHA’s response to time-sensitive payer policy and formulary changes that result in dealyed or non-coverage.
  2. The Insurance Advocacy Committee will spearhead long-term policy campaigns to promote constructive policy change within public payers, government institutions and specific healthcare fields (e.g., palliative care).
  3. The Insurance Advocacy Committee will create and review educational and outreach materials targeted at patients, medical professionals and payers.

The Insurance Advocacy Committee will convene periodically to discuss progress, evaluate goals and plan.

Ronald Oudiz, MD, Chair
Professor of Medicine
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institue at Harbor – UCLA Medical Center
Torrance, Calif.

Roham T. Zamanian, MD, FCCP
Assistant Professor of Medicine
Stanford School of Medicine
Stanford, Calif.

Brian Hanna, MD, PhD
The Children’s Hospital of Philadelphia
Philadelphia, Pa.

Allyson Rupp, LCSW
Licensed Clinical Social Worker
Vera M. Wall Center for Pulmonary Vascular Diseases
Stanford Hospital and Clinics
Stanford, Calif.

Tonya Zeiger, RRT, CPFT
Pulmonary Hypertension Coordinator
Mayo Clinic Florida
Jacksonville, Fla.

Alan Harder
PH Caregiver
Former SSA Employee